{"database": "lobbying", "table": "lobbying_activities", "rows": [[1414060, "e7ef17e8-15fb-4ef7-85e0-a76036d3e115", "Q2", "SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING", 35968, "SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING", 2013, "second_quarter", "PHA", "Pharmacy compounding of radiopharmaceuticals; S. 959, Pharmaceutical Quality, Security, and Accountability Act), nuclear medicine provisions.", "Centers For Medicare and Medicaid Services (CMS),Energy, Dept of,Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),Nuclear Regulatory Commission (NRC),SENATE", null, 110000, 0, 0, "2013-07-18T16:06:01.447000-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["1414060"], "units": {}, "query_ms": 13.022956089116633, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}